ACCORD HEALTHCARE, INC. recalls Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg), 1000-count bottle, Rx Only, Manufactured for: Accord Healthcare,
Recalled July 23, 2025 · FDA recall D-0524-2025 · ACCORD HEALTHCARE
Hazard
Subpotent Drug: Assay below the approved specification · FDA Class II
Units
2,344 bottles
Sold at
Nationwide in the USA
Description
Subpotent Drug: Assay below the approved specification
Product
Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg), 1000-count bottle, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-456-17
Manufacturer(s)
ACCORD HEALTHCARE, INC.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →